Članki z zahtevami za javni dostop - Thomas JakiVeč o tem
Umaknjeno: 10
Extrapolation of efficacy and other data to support the development of new medicines for children: a systematic review of methods
I Wadsworth, LV Hampson, T Jaki
Statistical methods in medical research 27 (2), 398-413, 2018
Zahteve: UK Medical Research Council, National Institute for Health Research, UK
Odgovorni avtorji: I Wadsworth
Adaptive clinical trials in tuberculosis: applications, challenges and solutions
GR Davies, PPJ Phillips, T Jaki
The International Journal of Tuberculosis and Lung Disease 19 (6), 626-634, 2015
Zahteve: UK Medical Research Council, National Institute for Health Research, UK
Odgovorni avtorji: GR Davies
Statistical approaches for the determination of cut points in anti-drug antibody bioassays
F Schaarschmidt, M Hofmann, T Jaki, B Grün, LA Hothorn
Journal of immunological methods 418, 84-100, 2015
Zahteve: UK Medical Research Council
Odgovorni avtorji: F Schaarschmidt
Bayesian adaptive dose‐escalation procedures for binary and continuous responses utilizing a gain function
WY Yeung, J Whitehead, B Reigner, U Beyer, C Diack, T Jaki
Pharmaceutical statistics 14 (6), 479-487, 2015
Zahteve: UK Medical Research Council, National Institute for Health Research, UK
Odgovorni avtorji: WY Yeung
Analysing malaria drug trials on a per‐individual or per‐clone basis: a comparison of methods
T Jaki, A Parry, K Winter, I Hastings
Statistics in medicine 32 (17), 3020-3038, 2013
Zahteve: UK Medical Research Council
Odgovorni avtorji: A Parry
Bayesian adaptive dose‐escalation designs for simultaneously estimating the optimal and maximum safe dose based on safety and efficacy
WY Yeung, B Reigner, U Beyer, C Diack, D Sabanés bové, G Palermo, ...
Pharmaceutical statistics 16 (6), 396-413, 2017
Zahteve: National Institute for Health Research, UK
Odgovorni avtorji: WY Yeung
A novel Phase I/IIa design for early phase oncology studies and its application in the evaluation of MK‐0752 in pancreatic cancer
J Whitehead, H Thygesen, T Jaki, S Davies, S Halford, H Turner, N Cook, ...
Statistics in Medicine 31 (18), 1931-1943, 2012
Zahteve: Cancer Research UK
Odgovorni avtorji: J Whitehead
A practical design for a dual‐agent dose‐escalation trial that incorporates pharmacokinetic data
A Cotterill, D Lorand, J Wang, T Jaki
Statistics in medicine 34 (13), 2138-2164, 2015
Zahteve: UK Medical Research Council, National Institute for Health Research, UK
Odgovorni avtorji: A Cotterill
A hybrid method to estimate the minimum effective dose for monotone and non‐monotone dose–response relationships
MJ Wolfsegger, G Gutjahr, W Engl, T Jaki
Biometrics 70 (1), 103-109, 2014
Zahteve: Austrian Science Fund, UK Medical Research Council
Odgovorni avtorji: MJ Wolfsegger
Adaptive Designs for Precision Medicine: Fundamental Statistical Considerations
DS Robertson, T Burnett, T Jaki, SS Villar
Handbook of Statistical Methods for Precision Medicine, 3-35, 2024
Zahteve: UK Medical Research Council, National Institute for Health Research, UK
Odgovorni avtorji: DS Robertson
Na voljo nekje: 189
A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19
B Cao, Y Wang, D Wen, W Liu, J Wang, G Fan, L Ruan, B Song, Y Cai, ...
New England journal of medicine 382 (19), 1787-1799, 2020
Zahteve: Bill & Melinda Gates Foundation, UK Medical Research Council, National …
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Y Wang, D Zhang, G Du, R Du, J Zhao, Y Jin, S Fu, L Gao, Z Cheng, Q Lu, ...
The Lancet 395 (10236), 1569-1578, 2020
Zahteve: Bill & Melinda Gates Foundation, National Natural Science Foundation of …
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
PW Horby, M Campbell, N Staplin, E Spata, JR Emberson, ...
The Lancet 397 (10285), 1637-1645, 2021
Zahteve: Bill & Melinda Gates Foundation, US National Institutes of Health, British …
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
P Horby, M Mafham, L Linsell, JL Bell, N Staplin, JR Emberson, M Wiselka, ...
The New England journal of medicine, 2020
Zahteve: Bill & Melinda Gates Foundation, Cancer Research UK, UK Medical Research …
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
PW Horby, M Mafham, JL Bell, L Linsell, N Staplin, J Emberson, ...
The Lancet 396 (10259), 1345-1352, 2020
Zahteve: Bill & Melinda Gates Foundation, Department of International Development, UK …
Adaptive designs in clinical trials: why use them, and how to run and report them
P Pallmann, AW Bedding, B Choodari-Oskooei, M Dimairo, L Flight, ...
BMC medicine 16, 1-15, 2018
Zahteve: Cancer Research UK, UK Medical Research Council, National Institute for …
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ...
The Lancet 400 (10349), 359-368, 2022
Zahteve: Bill & Melinda Gates Foundation, British Heart Foundation, UK Medical …
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
PW Horby, L Estcourt, L Peto, JR Emberson, N Staplin, E Spata, ...
Lancet 397 (10289), 2049-2059, 2021
Zahteve: Bill & Melinda Gates Foundation, British Heart Foundation, Cancer Research …
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
PW Horby, A Roddick, E Spata, N Staplin, J Emberson, G Pessoa-Amorim, ...
Lancet 397 (10274), 605-612, 2021
Zahteve: Bill & Melinda Gates Foundation, US National Institutes of Health, British …
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
PW Horby, M Mafham, L Peto, M Campbell, G Pessoa-Amorim, E Spata, ...
Lancet 399 (10325), 665-676, 2022
Zahteve: Bill & Melinda Gates Foundation, British Heart Foundation, UK Medical …
Podatke o objavi in financiranju samodejno določi računalniški program